课题基金 / 基金详情

CLINICAL TRIAL: PEDIATRIC PHARMACOKINETIC AND TOLERABILITY STUDY OF LITHIUM FOR

CLINICAL TRIAL: PEDIATRIC PHARMACOKINETIC AND TOLERABILITY STUDY OF LITHIUM FOR
临床试验:锂的儿科药代动力学和耐受性研究
批准号:
7719277
负责人:
VIVIAN KAFANTARIS
金额:
$17.59万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-22 至 2009-03-31

项目摘要

项目成果

VIVIAN KAFANTARIS的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 这是一项多阶段、多中心的试验,将全面检查锂在治疗儿童双相I型障碍患者中的作用。这项研究包括四个治疗阶段,包括药代动力学阶段、长期有效阶段、停用阶段和再稳定阶段。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a multiphase, multicenter, trial that will comprehensively examine lithium in the treatment of pediatric patients with bipolar I disorder. This study includes four treatment phases, including a pharmacokinetic phase, a long-term effectiveness phase, a discontinuation phase and a restabilization phase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3 ACISR
CLINICAL TRIAL: PEDIATRIC STUDY OF LITHIUM FOR THE TREATMENT OF PEDIATRIC MANIA
GENETICS OF EARLY-ONSET BIPOLAR DISORDER
TREATMENT AND OUTCOME IN EARLY-ONSET BIPOLAR DISORDER
海外基金